Grüezi! Sie wurden auf, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
SMI 10'221 0.9%  SPI 13'098 0.7%  Dow 29'684 1.9%  DAX 12'183 0.4%  Euro 0.9498 -0.2%  EStoxx50 3'335 0.2%  Gold 1'660 1.9%  Bitcoin 19'075 0.6%  Dollar 0.9760 -1.6%  Öl 89.2 4.1% 

News + Analysen
News + Adhoc
zugeh. Wertpapiere
Strukturierte Produkte
10.08.2022 19:15:41

1 Reason to Sell Novavax Stock, and 1 Reason to Buy

This year hasn't been an easy one for Novavax (NASDAQ: NVAX) investors. After a series of stumbles culminating in its disastrous earnings report on Aug. 8, its shares are down by 60% so far in 2022. And with management slashing its full-year revenue guidance by roughly half, there isn't much hope for smoother sailing for at least a few quarters.For a contrarian investor, that means the stock could be ripe for a buy with the goal of holding it through a turnaround. On the other hand, most of us aren't contrarians, so now could be the time to cut and run, or at least defer a purchase until conditions improve.On that note, here's one argument for selling your shares and one for buying more. Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"


Viele Anleger setzen deshalb auf den Aktiv verwalteten Global Inflation Protection Basket. Informieren Sie sich über die breit gestreute Auswahl an robusten Aktien & ETFs.